Skip to content

Author

Hideaki Nakasone

4 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Impact of Donor Age on Transplant Outcomes in Matched Unrelated Donor Transplantation for Myelofibrosis.

BACKGROUND Allogeneic hematopoietic cell transplantation (HCT) is the only curative therapy for myelofibrosis (MF), and donor selection remains one of the few modifiable determinants of outcome. As the unrelated donor pool ages, the impact of donor age in matched unrelated donor (MUD) HCT for MF has become increasingly...

K. Sakatoku, Yutaka Shimazu, Makoto Murata et al. · 0 citations
Sep 2026

Differential impact of GVHD prophylaxis on CMV infection and survival outcomes after cord blood transplantation in the era of letermovir.

Although recent studies suggested an enhanced graft-versus-tumor (GVT) effect with cord blood transplantation (CBT), higher rates of engraftment failure, acute graft-versus-host disease (GVHD), and infections, including cytomegalovirus (CMV), contribute to increased nonrelapse mortality (NRM). Thus, further optimizatio...

Shunto Kawamura, Y. Akahoshi, Hideaki Nakasone et al. · 0 citations
Oct 2026

Repertoire diversity and dynamics of peripheral Th17 after allogeneic haematopoietic stem cell transplantation.

Th17, a subset of helper T cells that produce interleukin-17 (IL-17), is thought to play a pivotal role in the pathogenesis of chronic graft-versus-host disease (GVHD). However, the kinetics of Th17 following allogeneic haematopoietic stem cell transplantation (allo-HSCT) have not been elucidated. In this study, we eva...

M. Tamaki, Hideaki Nakasone, Shunto Kawamura et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.